Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: The Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): A randomized, controlled pilot study

European Heart Journal

Volumn 28, Issue 17, 2007, Pages 2110-2117

  Erne, Paul ^a   Schoenenberger, Andreas W ^b   Zuber, Michel ^a   Burckhardt, Dieter ^c   Kiowski, Wolfgang ^d   Dubach, Paul ^e   Resink, Therese ^c   Pfisterer, Matthias ^c  

^a LUZERNER KANTONSSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d KLINIK IM PARK   (Switzerland)

^e KANTONSSPITAL GRAUBÜNDEN   (Switzerland)

Author keywords

Coronary artery disease; Drug therapy; Risk factor intervention; Silent ischaemia

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; NITRATE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; EXERCISE; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SILENT MYOCARDIAL INFARCTION; ST SEGMENT DEPRESSION; TIME; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AMLODIPINE; BISOPROLOL; DEATH, SUDDEN, CARDIAC; HUMANS; MIDDLE AGED; MOLSIDOMINE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PATIENT COMPLIANCE; PILOT PROJECTS; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34948903237     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm273     Document Type: Article

References (28)

1. Conti CR. Silent cardiac ischemia. Curr Opin Cardiol 2002;17:537-542.
2. Cohn PF. Silent myocardial ischemia: recent developments. Curr Atheroscler Rep 2005;7:155-163.
3. Cohn PF, Fox KM, Daly C. Silent myocardial ischemia. Circulation 2003;108:1263-1277.
4. Osterspey A, Treis-Muller I, Gunther H, Eggeling T, Siglow C, Gedicke V, Hopp H, Diewitz M, Osterhues H, Hilger HH. Silent ischaemia in asymptomatic 'healthy' individuals with coronary risk factors. Eur Heart J 1988;9(Suppl. N):65-69.
5. Froelicher VF, Thompson AJ, Longo MR Jr, Triebwasser JH, Lancaster MC. Value of exercise testing for screening asymptomatic men for latent coronary artery disease. Prog Cardiovasc Dis 1976;18:265-276.
6. Hung J, Goris ML, Nash E, Kraemer HC, DeBusk RF, Berger WE III, Lew H. Comparative value of maximal treadmill testing, exercise thallium myocardial perfusion scintigraphy and exercise radionuclide ventriculography for distinguishing high- and low-risk patients soon after acute myocardial infarction. Am J Cardiol 1984;53:1221-1227.
7. Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Poldermans D. Comparison of late outcome in patients with versus without angina pectoris having reversible perfusion abnormalities during dobutamine stress technetium-99m sestamibi single-photon emission computed tomography. Am J Cardiol 2003;91:264-268.
8. Penfornis A, Zimmermann C, Boumal D, Sabbah A, Meneveau N, Gaultier-Bourgeois S, Bassand JP, Bernard Y. Use of dobutamine stress echocardiography in detecting silent myocardial ischaemia in asymptomatic diabetic patients: a comparison with thallium scintigraphy and exercise testing. Diabet Med 2001;18:900-905.
9. Fleg JL, Gerstenblith G, Zonderman AB, Becker LC, Weisfeldt ML, Costa PT Jr, Lakatta EG. Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers. Circulation 1990;81:428-436.
10. Tzivoni D, Gavish A, Zin D, Gottlieb S, Moriel M, Keren A, Banai S, Stern S. Prognostic significance of ischemic episodes in patients with previous myocardial infarction. Am J Cardiol 1988;62:661-664.
11. Erne P, Schoenenberger AW, Burckhardt D, Zuber M, Kiowski W, Buser PT, Dubach P, Resink TJ, Pfisterer M. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA 2007;297:1985-1991.
12. De Lorenzo F, Saba N, Dancy M, Kakkar VV, Kadziola Z, Xiao HB. Induced ischemia detected by dobutamine stress echocardiography in coronary heart disease patients after myocardial re-vascularization. Experience in a District General Hospital. Int J Cardiol 2002;83:119-124.
13. Zellweger MJ, Weinbacher M, Zutter AW, Jeger RV, Mueller-Brand J, Kaiser C, Buser PT, Pfisterer ME. Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting. J Am Coll Cardiol 2003;42:33-40.
14. Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatterud GL, Geller N, Sopko G, Pratt C, Deanfield J, Conti CR. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95:2037-2043.
15. Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, Miller E, Marks RG, Thadani U. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation 1994;90:762-768.
16. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502- 1513.
17. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187-220.
18. Thaulow E, Erikssen J, Sandvik L, Erikssen G, Jorgensen L, Cohn PF. Intitial clinical presentation of cardiac disease in asymptomatic men with silent myocardial ischaemia and angiographically documented coronary artery disease (the Oslo Ischaemia Study). Am J Cardiol 1993;72:629-633.
19. de Torbal A, Boersma E, Kors JA, van Herpen G, Deckers JW, van der Kuip DAM, Stricker BH, Hofman A, Wittemann JCM. Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. Eur Heart J 2006;27:729-736.
20. Fleg JL. Myocardial ischemia in the asymptomatic older patient. Am J Geriatr Cardiol 1998;7:54-59.
21. Aronow WS, Ahn C, Mercando AD, Epstein S, Kronzon I. Prevalence of and association between silent myocardial ischemia and new coronary events in older men and women with and without cardiovascular disease. J Am Geriatr Soc 2002;50:1075-1078.
22. Sigurdsson E, Sigfusson N, Sigvaldason H, Thorgeirsson G. Silent ST-T changes in an epidemiologic cohort study - a marker of hypertension or coronary heart disease, or both: the Reykjavik Study. J Am Coll Cardiol 1996;27:1140-1147.
23. Laukkanen JA, Kurl S, Lakka TA, Tuomainen TP, Rauramaa R, Salonen R, Eranen J, Salonen JT. Exercise-induced silent myocardial ischemia and coronary morbidity and mortality in middle-aged men. J Am Coll Cardiol 2001;38:72-79.
24. Fruhwald FM, Eber B, Toplak H, Fruhwald SM, Dusleag J, Patzold D, Harnoncourt K, Klein W. 10-year-follow-up of patients with silent Cohn type 1 myocardial ischemia. Acta Med Austriaca 1994;21:89-93.
25. Mulcahy D, Fox K. Can we really justify the treatment of silent ischemia in 1992? No!. Cardiovasc Drugs Ther 1992;6:125-129.
26. Fazzini PF, Prati PL, Rovelli F, Antoniucci D, Menghini F, Seccareccia F, Menotti A. Epidemiology of silent myocardial ischemia in asymptomatic middle-aged men (the ECCIS Project). Am J Cardiol 1993;72:1383- 1388.
27. Nyman I, Larsson H, Wallentin L. Prevention of serious cardiac events by low-dose aspirin in patients with silent myocardial ischemia. Lancet 1992;340:497-501.
28. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GBJ, Weintraub WS for the COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-1516.